Found: 136
Select item for more details and to access through your institution.
The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 64, doi. 10.1002/cpt.3275
- By:
- Publication type:
- Article
Uptake of orphan drugs in the WHO essential medicines lists.
- Published in:
- Bulletin of the World Health Organization, 2024, v. 102, n. 1, p. 22, doi. 10.2471/BLT.23.289731
- By:
- Publication type:
- Article
Medicine shortages: impact behind numbers.
- Published in:
- Journal of Pharmaceutical Policy & Practice, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s40545-023-00548-x
- By:
- Publication type:
- Article
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement.
- Published in:
- International Journal of Technology Assessment in Health Care, 2023, v. 39, n. 1, p. 1, doi. 10.1017/S0266462323000144
- By:
- Publication type:
- Article
Longitudinal study of Good Pharmacy Practice roles covered at the annual world pharmacy congresses 2003–2019.
- Published in:
- Journal of Pharmaceutical Policy & Practice, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s40545-022-00482-4
- By:
- Publication type:
- Article
Impact of medicine shortages on patients - a framework and application in the Netherlands.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Impact of medicine shortages on patients - a framework and application in the Netherlands.
- Published in:
- BMC Health Services Research, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12913-022-08765-x
- By:
- Publication type:
- Article
Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.948161
- By:
- Publication type:
- Article
The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pre‐approval and post‐approval availability of evidence and clinical benefit of conditionally approved cancer drugs in Europe: A comparison with standard approved cancer drugs.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 5, p. 2169, doi. 10.1111/bcp.15141
- By:
- Publication type:
- Article
The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs.
- Published in:
- International Journal of Health Policy & Management, 2022, v. 11, n. 5, p. 642, doi. 10.34172/ijhpm.2020.198
- By:
- Publication type:
- Article
Addressing uncertainty in relative effectiveness assessments by HTA organizations.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, n. 1, p. 1, doi. 10.1017/S026646232100177X
- By:
- Publication type:
- Article
Addressing uncertainty in relative effectiveness assessments by HTA organizations.
- Published in:
- International Journal of Technology Assessment in Health Care, 2021, v. 38, n. 1, p. 1, doi. 10.1017/S026646232100177X
- By:
- Publication type:
- Article
Comment on "Deterministic Sensitivity Analysis Under Ignorance".
- Published in:
- 2021
- By:
- Publication type:
- Letter
Switching TNFα inhibitors: Patterns and determinants.
- Published in:
- Pharmacology Research & Perspectives, 2021, v. 9, n. 4, p. 1, doi. 10.1002/prp2.843
- By:
- Publication type:
- Article
Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 4, p. 1566, doi. 10.1111/cts.13027
- By:
- Publication type:
- Article
Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E2, doi. 10.1002/ajh.26007
- By:
- Publication type:
- Article
The Application and Implications of Novel Deterministic Sensitivity Analysis Methods.
- Published in:
- PharmacoEconomics, 2021, v. 39, n. 1, p. 1, doi. 10.1007/s40273-020-00979-3
- By:
- Publication type:
- Article
Getting the Right Evidence After Drug Approval.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.569535
- By:
- Publication type:
- Article
Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 2, p. 350, doi. 10.1002/cpt.1835
- By:
- Publication type:
- Article
Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 6, p. 883, doi. 10.1007/s40258-019-00496-1
- By:
- Publication type:
- Article
Tenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghana.
- Published in:
- BMC Research Notes, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13104-019-4454-2
- By:
- Publication type:
- Article
Exploring the Association between Monoclonal Antibodies and Depression and Suicidal Ideation and Behavior: A VigiBase Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Potentially inappropriate medications with risk of cardiovascular adverse events in the elderly: A systematic review of tools addressing inappropriate prescribing.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2019, v. 44, n. 3, p. 349, doi. 10.1111/jcpt.12811
- By:
- Publication type:
- Article
The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrations.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 5, p. 563, doi. 10.1002/pds.4747
- By:
- Publication type:
- Article
Post‐marketing dosing changes in the label of biologicals.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 4, p. 715, doi. 10.1111/bcp.13843
- By:
- Publication type:
- Article
Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: a modified cohort event monitoring study in public health facilities in Ghana and Uganda.
- Published in:
- Malaria Journal, 2019, v. 18, n. 1, p. 1, doi. 10.1186/s12936-019-2670-9
- By:
- Publication type:
- Article
Postauthorization Changes to Specific Obligations of Conditionally Authorized Medicines in the European Union: A Retrospective Cohort Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 426, doi. 10.1002/cpt.1169
- By:
- Publication type:
- Article
Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Drug Shortages From the Perspectives of Authorities and Pharmacy Practice in the Netherlands: An Observational Study.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.01243
- By:
- Publication type:
- Article
Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, p. 19, doi. 10.1111/dom.13453
- By:
- Publication type:
- Article
Comparing safety information of biosimilars with their originators: a cross‐sectional analysis of European risk management plans.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 4, p. 738, doi. 10.1111/bcp.13454
- By:
- Publication type:
- Article
When More Is Less: An Exploratory Study of the Precautionary Reporting Bias and Its Impact on Safety Signal Detection.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 2, p. 296, doi. 10.1002/cpt.879
- By:
- Publication type:
- Article
Global Regulatory Differences for Gene- and Cell-Based Therapies: Consequences and Implications for Patient Access and Therapeutic Innovation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 1, p. 120, doi. 10.1002/cpt.894
- By:
- Publication type:
- Article
Pharmacological vs. classical approaches in the design of first in man clinical drug trials.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 12, p. 2807, doi. 10.1111/bcp.13422
- By:
- Publication type:
- Article
Reviewers of manuscripts submitted in 2016: With appreciation.
- Published in:
- 2017
- By:
- Publication type:
- Other
Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 401, doi. 10.1111/dom.12833
- By:
- Publication type:
- Article
Long-term use of dipeptidyl peptidase-4 inhibitors and risk of fracture: A retrospective population-based cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 421, doi. 10.1111/dom.12843
- By:
- Publication type:
- Article
Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2017, v. 26, n. 1, p. 1, doi. 10.1002/pds.4125
- By:
- Publication type:
- Article
Reviewers of Manuscripts Submitted in 2015: With Appreciation.
- Published in:
- 2017
- By:
- Publication type:
- Other
Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials.
- Published in:
- PLoS ONE, 2016, v. 11, n. 12, p. 1, doi. 10.1371/journal.pone.0167709
- By:
- Publication type:
- Article
Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effects of over-the-counter sales restriction of antibiotics on substitution with medicines for symptoms relief of cold in Mexico and Brazil: time series analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 2369, doi. 10.2147/PPA.S116860
- By:
- Publication type:
- Article
Relationship between Age and the Ability to Break Scored Tablets.
- Published in:
- Frontiers in Pharmacology, 2016, p. 1, doi. 10.3389/fphar.2016.00222
- By:
- Publication type:
- Article
Insulin glargine use and breast cancer risk: Associations with cumulative exposure.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 7, p. 851, doi. 10.3109/0284186X.2016.1155736
- By:
- Publication type:
- Article
Characteristics and follow-up of postmarketing studies of conditionally authorized medicines in the EU.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 1, p. 213, doi. 10.1111/bcp.12940
- By:
- Publication type:
- Article